Immunovant, Inc. (IMVT)
37.36
-0.74
(-1.94%)
USD |
NASDAQ |
Sep 11, 16:00
37.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunovant Market Cap : 7.706B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 7.706B |
| September 10, 2026 | 7.859B |
| September 09, 2026 | 7.993B |
| September 08, 2026 | 8.162B |
| September 04, 2026 | 8.096B |
| September 03, 2026 | 8.069B |
| September 02, 2026 | 8.145B |
| September 01, 2026 | 8.230B |
| August 31, 2026 | 8.420B |
| August 28, 2026 | 8.498B |
| August 27, 2026 | 9.039B |
| August 26, 2026 | 9.053B |
| August 25, 2026 | 8.973B |
| August 24, 2026 | 8.935B |
| August 21, 2026 | 9.152B |
| August 20, 2026 | 9.148B |
| August 19, 2026 | 9.274B |
| August 18, 2026 | 9.138B |
| August 17, 2026 | 9.016B |
| August 14, 2026 | 8.626B |
| August 13, 2026 | 8.626B |
| August 12, 2026 | 8.787B |
| August 11, 2026 | 8.442B |
| August 10, 2026 | 8.228B |
| August 07, 2026 | 8.240B |
| Date | Value |
|---|---|
| August 06, 2026 | 8.197B |
| August 05, 2026 | 8.102B |
| August 04, 2026 | 8.119B |
| August 03, 2026 | 7.854B |
| July 31, 2026 | 7.876B |
| July 30, 2026 | 8.052B |
| July 29, 2026 | 7.874B |
| July 28, 2026 | 7.933B |
| July 27, 2026 | 8.176B |
| July 24, 2026 | 8.037B |
| July 23, 2026 | 8.029B |
| July 22, 2026 | 7.964B |
| July 21, 2026 | 8.062B |
| July 20, 2026 | 8.141B |
| July 17, 2026 | 8.211B |
| July 16, 2026 | 7.946B |
| July 15, 2026 | 8.133B |
| July 14, 2026 | 7.907B |
| July 13, 2026 | 7.892B |
| July 10, 2026 | 8.098B |
| July 09, 2026 | 8.380B |
| July 08, 2026 | 8.221B |
| July 07, 2026 | 8.176B |
| July 06, 2026 | 7.872B |
| July 02, 2026 | 7.911B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 57.44B |
| Altimmune, Inc. | 635.93M |
| TG Therapeutics, Inc. | 8.249B |
| Dianthus Therapeutics, Inc. | 5.820B |
| First Tracks Biotherapeutics, Inc. | 1.290B |
Market Cap Related Metrics
| Price to Book Value | 10.48 |
| Price | 37.36 |
| Earnings Yield | -7.52% |